Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2024Current Drug Delivery

Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

GDGaidaa M. DogheimSCSampath ChinnamMAMohamed T. Amralla

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dogheim et al. (2024) studied this question.

synapsesocial.com/papers/68e6bd2cb6db64358763d17ahttps://doi.org/10.2174/0115672018292331240404070236
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in Lipid-Based Nanomedicine: Pathway Specific siRNA Therapy and Optimizing Delivery for Hepatocellular Carcinoma2025 · 14 citations
  2. 2Lipid-based nanomedicine for hepatocellular carcinoma: flavonoid-enhanced, pathway-specific siRNA delivery strategies and clinical progress2026
  3. 3Nanoscale Delivery Systems for Hepatocellular Carcinoma: Functionalization, Delivery Strategies, and Clinical Challenges2026 · 3 citations
  4. 4[Advances in Nanotechnology-Based Drug Delivery Systems in the Treatment of Hepatocellular Carcinoma].2024
  5. 5Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers2026 · 1 citations